CureMetrix vs Gleamer
CureMetrix serves breast imaging groups. cmAngio has three FDA decisions, K232367 in October 2023, K250754 in April 2025 and K260980 in July 2026, and cmTriage scores screening mammograms for read order.
Gleamer's buyer is a hospital radiology department or imaging network reading emergency X-rays. BoneView flags fractures, dislocations and bone lesions on limbs, pelvis, spine and ribs, ChestView covers pneumothorax, consolidation and nodules, and the vendor says AI prioritizes the worklist through the RIS. A 2025 systematic review of BoneView appeared in European Journal of Radiology. Since March 2026 the company has been part of RadNet's DeepHealth.
For a US group that wants FDA-cleared mammography AI today, Gleamer falls behind. Its openFDA records name BoneView, BoneMetrics and ChestView, and BreastView, which the vendor lists on its site, is not among them.
Radiology · Reviewed November 2, 2026
CureMetrix
by CureMetrix
AI for mammograms: cmAngio quantifies breast arterial calcification (FDA-cleared), cmTriage prioritizes screening exams.
Gleamer
by Gleamer SAS
Radiology AI for fracture and chest X-ray findings, plus CT, MRI and mammography; part of RadNet DeepHealth since March 2026.
When to pick each one
CureMetrix
- Three cmAngio clearances, October 2023 to July 2026
- cmTriage prioritizes screening mammograms for reading
- Latest cmAngio V2.0, K260980, July 2026
Gleamer
- BoneView fracture detection for adults and children over 2
- ChestView for pneumothorax, nodules and effusion
- Worklist prioritization through the RIS, per the vendor
Score
Each row shows points earned of points available under the published rubric.
CureMetrix
48of 100
Gleamer
56of 100
| Dimension | CureMetrix | Gleamer | Difference |
|---|---|---|---|
| FDA clearance | 18 / 18 | 18 / 18 | 0 |
| HIPAA / SOC2 / BAA | 0 / 10 | 0 / 10 | 0 |
| EHR integrations (count) | 0 / 4.2 | 0 / 4.2 | 0 |
| Top-3 EHR coverage (Epic / Oracle / Athena) | 0 / 2.4 | 0 / 2.4 | 0 |
| Peer-reviewed papers | 12.7 / 18.2 | 18.2 / 18.2 | -5.5 |
| RCT / meta-analysis / systematic review | 3.9 / 7.8 | 0 / 7.8 | +3.9 |
| Funding & adoption signal | 3 / 12 | 8.4 / 12 | -5.4 |
| Pricing transparency | 2.5 / 5 | 2.5 / 5 | 0 |
| Years in market | 0 / 6 | 0 / 6 | 0 |
Scroll horizontally to see every column.
Pricing
CureMetrix
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. The homepage shows none. |
Gleamer
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. Demo request only. |
Evidence
CureMetrix
FDA decisions
K260980 (opens in new tab)510(k)2026-07-30
cmAngio V2.0
K250754 (opens in new tab)510(k)2025-04-10
cmAngio V1.6
K232367 (opens in new tab)510(k)2023-10-05
cmAngio V1.0
K183285 (opens in new tab)510(k)2019-03-08
cmTriage
Peer-reviewed
3 PubMed records name CureMetrix.
- A Novel Breast Arterial Calcification Age-Based Percentile Nomogram for the Incremental Prediction of Incidental Cardiovascular Events. (opens in new tab)
- Evaluation of an Artificial Intelligence System for Detection of Invasive Lobular Carcinoma on Digital Mammography. (opens in new tab)
- Multicenter, Multivendor Validation of an FDA-approved Algorithm for Mammography Triage. (opens in new tab)
Gleamer
FDA decisions
K252486 (opens in new tab)510(k)2026-09-09
ChestView US (1.1)
K241620 (opens in new tab)510(k)2025-02-27
ChestView US
K241593 (opens in new tab)510(k)2025-02-05
BoneMetrics (US)
K213253 (opens in new tab)510(k)2023-06-30
Pixyl.Neuro
K222176 (opens in new tab)510(k)2023-03-02
BoneView
Show 1 more
K212365 (opens in new tab)510(k)2022-03-01
BoneView
Peer-reviewed
5 PubMed records name Gleamer.
- Opinion paper: artificial intelligence as a clinical ally in lung cancer detection-the case for Gleamer's ChestView. (opens in new tab)
- AI model for automatic spinopelvic and spinal alignment parameters measurement from EOS. (opens in new tab)
- Fracture Detection on Bone Radiographs: The Impact of an AI Tool on Orthopaedic Night Shifts. (opens in new tab)
Compliance and integrations
Documented from each vendor’s own pages.
| Spec | CureMetrix | Gleamer |
|---|---|---|
| Free tier | ||
| HIPAA | ||
| SOC 2 Type II | ||
| EHR integrations | Not specified | Not specified |
| Founded | n/a | n/a |
| HQ | US | FR |
Scroll horizontally to see both columns.
Common questions
Open the full radiology comparison
Acute-care triage, mammography screening, CCTA plaque analysis, mobile MRI. 30+ FDA-cleared platforms across stroke, oncology, cardiac. Enterprise sales only — we compared what's deployed where.